VNRX - VOLITIONRX LTD
2.78
2.644 95.101%
Share volume: 377,519
Last Updated: 04-28-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.14
0.06
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 11-14-2024 | 05-15-2025 | 08-14-2025 | 11-13-2025 | |
| Assets | ||||||
| Total Assets | 19.435 M | 12.680 M | 8.520 M | 8.705 M | 6.449 M | |
| Current Assets | 13.470 M | 6.801 M | 3.294 M | 3.263 M | 1.332 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 1.564 M | 384.189 K | 255.769 K | 343.246 K | 363.515 K | |
| Short Term Investments | 1.564 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 133.500 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 11.772 M | 5.414 M | 2.600 M | 2.256 M | 199.407 K | |
| Total Non-current Assets | 5.965 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 5.181 M | 4.908 M | 4.348 M | 4.500 M | 4.243 M | |
| Other Assets | 0.000 | 971.166 K | 877.739 K | 941.418 K | 873.322 K | |
| Intangible Assets | 215.133 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 19.435 M | 12.680 M | 8.520 M | 8.705 M | 6.449 M | |
| Total liabilities | 35.040 M | 35.321 M | 37.547 M | 41.803 M | 42.398 M | |
| Total current liabilities | 31.492 M | 30.279 M | 8.273 M | 9.241 M | 11.422 M | |
| Accounts Payable | 3.528 M | 2.485 M | 3.012 M | 2.351 M | 3.114 M | |
| Other liabilities | 413.968 K | 388.898 K | 377.662 K | 443.911 K | 442.494 K | |
| Current long term debt | 1.198 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 3.752 M | 3.838 M | 5.532 M | 8.692 M | 7.824 M | |
| Other liabilities | 413.968 K | 388.898 K | 377.662 K | 443.911 K | 442.494 K | |
| Minority interest | -1.015 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -15.605 M | -21.504 M | -27.774 M | -31.815 M | -34.635 M | |
| Common stock | 81.957 M | 202.107 M | 207.063 M | 209.881 M | 212.417 M | |
| Retained earnings | -210.944 M | -223.751 M | -234.968 M | -241.252 M | -246.631 M |